RELISTOR sol inj 12 mg/0.6ml flac 7 pce

7680586520029 CH-58652 A06AH01 04.99.0.
RELISTOR sol inj 12 mg/0.6ml flac 7 pce
RELISTOR sol inj 12 mg/0.6ml flac 7 pce
RELISTOR sol inj 12 mg/0.6ml flac 7 pce
1 / 3
google

Details

Product number
5865201
CPT
-
Packaging group
7
Unit
Durchstechflasche(n)
Composition
methylnaltrexonii bromidum 12 mg, natrii chloridum, natrii calcii edetas, glycini hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml.

Articles (1)

Relistor, Injektionslösung
Injektionslösung
7
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
03/03/2025
Professional SmPC
Français
03/03/2025
Professional SmPC
Italien
03/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
12.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
4.14 MG Substance HBESI

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
58652
Drug name
Relistor, Injektionslösung
Galenic form
LSPA
ATC Code
A06AH01
Authorization status
Z
Dispensation category
B
First authorization
15/04/2009
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Opiat-induzierte Obstipation

Packaging details

Description (FR)
RELISTOR sol inj 12 mg/0.6ml flac 7 pce
Description (DE)
RELISTOR Inj Lös 12 mg/0.6ml Durchstf 7 Stk
Market launch
15/04/2009
Narcotic (BTM)
No

Other packaging sizes

RELISTOR sol inj 12 mg/0.6ml flac
1 DUR
View